Risk for COVID-19 infection in patients with tobacco smoke-associated cancers of the upper and lower airway
Review Article
Published on
Journal: European archives of oto-rhino-laryngology : offic [Category] COVID-19, MERS, SARS,
Journal: European archives of oto-rhino-laryngology : offic [Category] COVID-19, MERS, SARS,
[키워드] ACE2
Activation
advanced age
airway
Cancer
cerebrovascular diseases
characterized
chronic inflammation
chronic obstructive
clinical
Clinical course
Clinical outcome
Comorbidity
condition
COPD
COVID-19
COVID-19 infection
COVID-19 patient
cytokine
cytokine release
epithelial
Factor
Gender
Head neck cancer
iatrogenic
IL-6
immune
Immunity
impairment
increased risk
Infection
Inflammation
inflammatory cell
Interaction
interleukin-6
key factor
lower airway
lung cancer
male
morbidity and mortality
Multi-organ damage
nasal
occur
overexpressed
pathophysiological
Patient
Patients with cancer
receptors
respiratory cell
Respiratory disease
respiratory infectious disease
Result
review
risk
Risk factors
SARS-CoV-2 replication
smoker
Smokers
syndrome
the cytokine storm
TMPRSS2
tobacco smoke
triggering
viral infection
[DOI] 10.1007/s00405-020-06456-z PMC 바로가기 [Article Type] Review Article
[DOI] 10.1007/s00405-020-06456-z PMC 바로가기 [Article Type] Review Article